Acorah Software Products - Accounts Production 16.0.110 false true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 02611177 Dr John Frazer Mrs Claire Frazer iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 02611177 2023-03-31 02611177 2024-03-31 02611177 2023-04-01 2024-03-31 02611177 frs-core:CurrentFinancialInstruments 2024-03-31 02611177 frs-core:ComputerEquipment 2024-03-31 02611177 frs-core:ComputerEquipment 2023-04-01 2024-03-31 02611177 frs-core:ComputerEquipment 2023-03-31 02611177 frs-core:FurnitureFittings 2024-03-31 02611177 frs-core:FurnitureFittings 2023-04-01 2024-03-31 02611177 frs-core:FurnitureFittings 2023-03-31 02611177 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-03-31 02611177 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 02611177 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2023-03-31 02611177 frs-core:MotorVehicles 2024-03-31 02611177 frs-core:MotorVehicles 2023-04-01 2024-03-31 02611177 frs-core:MotorVehicles 2023-03-31 02611177 frs-core:PlantMachinery 2024-03-31 02611177 frs-core:PlantMachinery 2023-04-01 2024-03-31 02611177 frs-core:PlantMachinery 2023-03-31 02611177 frs-core:ShareCapital 2024-03-31 02611177 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 02611177 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 02611177 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 02611177 frs-bus:SmallEntities 2023-04-01 2024-03-31 02611177 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 02611177 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 02611177 frs-core:ListedExchangeTraded 2024-03-31 02611177 frs-core:ListedExchangeTraded 2023-03-31 02611177 frs-core:CostValuation frs-core:ListedExchangeTraded 2023-03-31 02611177 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-03-31 02611177 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2023-03-31 02611177 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-03-31 02611177 frs-bus:Director1 2023-04-01 2024-03-31 02611177 frs-bus:CompanySecretary1 2023-04-01 2024-03-31 02611177 frs-countries:EnglandWales 2023-04-01 2024-03-31 02611177 2022-03-31 02611177 2023-03-31 02611177 2022-04-01 2023-03-31 02611177 frs-core:CurrentFinancialInstruments 2023-03-31 02611177 frs-core:ShareCapital 2023-03-31 02611177 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31
Registered number: 02611177
Frazer Medical Research Limited
Unaudited Financial Statements
For The Year Ended 31 March 2024
Unaudited Financial Statements
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 02611177
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 59,064 71,494
Investments 5 49,737 49,737
108,801 121,231
CURRENT ASSETS
Debtors 6 35,177 50,417
Cash at bank and in hand 198,023 95,670
233,200 146,087
Creditors: Amounts Falling Due Within One Year 7 (57,846 ) (87,952 )
NET CURRENT ASSETS (LIABILITIES) 175,354 58,135
TOTAL ASSETS LESS CURRENT LIABILITIES 284,155 179,366
NET ASSETS 284,155 179,366
CAPITAL AND RESERVES
Called up share capital 8 100 100
Profit and Loss Account 284,055 179,266
SHAREHOLDERS' FUNDS 284,155 179,366
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr John Frazer
Director
28/10/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Frazer Medical Research Limited is a private company, limited by shares, incorporated in England & Wales, registered number 02611177 . The registered office is Hazeldene 32 Hall Drive, Bramhope, Leeds, West Yorkshire, LS16 9JE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold on Director's valuations
Plant & Machinery 15% reducing balance
Motor Vehicles 25% reducing balance
Fixtures & Fittings 15% reducing balance
Computer Equipment 30% reducing balance
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
4. Tangible Assets
Land & Property
Freehold Plant & Machinery Motor Vehicles Fixtures & Fittings
£ £ £ £
Cost
As at 1 April 2023 8,000 92,328 43,199 23,158
As at 31 March 2024 8,000 92,328 43,199 23,158
Depreciation
As at 1 April 2023 - 59,494 14,175 21,547
Provided during the period - 4,925 7,256 242
As at 31 March 2024 - 64,419 21,431 21,789
Net Book Value
As at 31 March 2024 8,000 27,909 21,768 1,369
As at 1 April 2023 8,000 32,834 29,024 1,611
Computer Equipment Total
£ £
Cost
As at 1 April 2023 2,394 169,079
As at 31 March 2024 2,394 169,079
Depreciation
As at 1 April 2023 2,369 97,585
Provided during the period 7 12,430
As at 31 March 2024 2,376 110,015
Net Book Value
As at 31 March 2024 18 59,064
As at 1 April 2023 25 71,494
5. Investments
Listed
£
Cost
As at 1 April 2023 49,737
As at 31 March 2024 49,737
Provision
As at 1 April 2023 -
As at 31 March 2024 -
...CONTINUED
Page 4
Page 5
Net Book Value
As at 31 March 2024 49,737
As at 1 April 2023 49,737
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 21,433 36,673
Prepayments and accrued income 3,744 3,744
Other debtors 10,000 10,000
35,177 50,417
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Corporation tax 41,171 15,579
Other taxes and social security 1,677 1,261
VAT 11,639 7,813
Accruals and deferred income 3,000 3,000
Directors' loan accounts 359 60,299
57,846 87,952
8. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
Page 5